Verified active February 2, 2026

Key Highlights

  • UCB's mission-driven approach focuses on improving the lives of patients with severe conditions, emphasizing real-world impact beyond clinical outcomes.
  • The company's global presence and collaborative culture enable cutting-edge research and innovation shaped by patient needs.
  • UCB's commitment to respect, care, and thoughtful intent reflects its dedication to serving the patient community.
  • The company's strategic partnerships with healthcare professionals and communities enhance its ability to deliver meaningful solutions.
  • UCB's ambition to unlock transformative science and technologies positions it as a leader in addressing unmet needs and elevating lives.

About UCB

UCB is a privately held company founded in 1928, dedicated to improving the lives of people with severe central nervous system and immunological conditions. With a global presence in nearly 40 countries, UCB focuses on delivering meaningful solutions that extend beyond medicine, aiming to enhance everyday life for patients. The company nurtures a culture of respect and care, collaborating across borders to enable cutting-edge research shaped by patients’ needs.

UCB's mission is driven by the experiences of patients and caregivers, inspiring innovations that create real value in clinical outcomes and daily life. By listening deeply and working with healthcare professionals, partners, and communities, UCB strives to make a lasting impact. The company's ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives.

UCB employs 14,293 people worldwide, fostering a culture of thoughtful intent and collaboration. The company's headquarters are in Belgium, and it operates with a commitment to reflecting the voices of those it serves in all its work.

Company Facts

Ownership Public Company
Parent Company University of California

Office Locations

  • 50 global learning centers

Connect with UCB

Why Contact UCB?

B2B professionals should contact UCB for opportunities in delivering innovative solutions for severe central nervous system and immunological conditions. UCB offers potential partnerships and vendor opportunities for those in the healthcare and pharmaceutical industries.

Who Should Contact UCB for Business?

Sales teams selling healthcare solutions, recruiters seeking roles in pharmaceuticals, and partners offering research and development capabilities should reach out to UCB.

Categories

  • Pharmaceutical
  • Healthcare
  • Immunological
  • Research
  • Innovation
  • Patient-driven
  • Global presence
  • Collaborative culture
  • Transformative science
  • Real-world impact

Similar Companies

Companies that compete with or operate in similar markets to UCB:

  • Stanford University

More Pharmaceutical Research Companies

Frequently Asked Questions

What does UCB do?
UCB (University of California, Berkeley) is a comprehensive public research university that offers undergraduate and graduate programs, including a highly-regarded mathematics department, and provides opportunities for global exchange and internships.
How many employees does UCB have?
UCB has approximately 14.4K employees.
What industry is UCB in?
UCB operates in Pharmaceutical Research, Healthcare Solutions, Immunological Therapies.
When was UCB founded?
UCB was founded in 1928.
What is the email format at UCB?
UCB uses the email format first.last@ucb.com.
Is UCB still active?
Yes, UCB was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
How do I sell to UCB?
Research UCB's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.

Ready to Sell to UCB?

Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.

Discover Similar Companies
Find Decision Makers
Outreach Monitoring

View pricing · FAQs · Contact us

Last verified: February 2, 2026

Backed by startup programs from